We are live on ! Find out more
PTVE

Pactiv Evergreen Inc. Common stock

Delisted

PTVE was delisted on the 31st of March, 2025.

0 hedge funds and large institutions have $0 invested in Pactiv Evergreen Inc. Common stock in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 162 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1630 (-163)

100% less funds holding in top 10

Funds holding in top 10: 40 (-4)

100% less capital invested

Capital invested by funds: $785M → $0 (-$785M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 162

Holders
Holders Change
-163
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
162
Calls
Puts
Net Calls
Net Calls Change

PTVE Hedge Fund Activity: Q2 2025 in Review

0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q2 2025, worth a combined $0 — down 100% from $785M a quarter earlier.

Sellers outnumbered buyers: 162 funds closed out of PTVE and 0 opened new positions — a net loss of 162 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $66.5M sold.

  • 0 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q2 2025, down from 163 in Q1 2025.
  • Funds reported $0 of Pactiv Evergreen Inc. Common stock stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Pactiv Evergreen Inc. Common stock positions in Q2 2025 and 162 closed out, a net change of -162 holders.
  • The largest Pactiv Evergreen Inc. Common stock seller in Q2 2025 was Vanguard Group, an estimated $66.5M sold.

Based on aggregated 13F filings for Q2 2025.